4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan
By Adam Lidgett · January 26, 2022, 8:03 PM EST
A split Fourth Circuit panel has refused to revive a False Claims Act suit alleging an Allergan unit fraudulently reported drug prices to Medicaid and cost the federal government at least...
To view the full article, register now.